FLT3 Inhibitors as Maintenance Therapy after Allogeneic Stem-Cell Transplantation

Blackmon A, Aldoss I, Ball BJ

Blood and Lymphatic Cancer: Targets and Therapy 2022, 12:137-147

Published Date: 6 September 2022